security diagnostic IPO: The issue will open for subscription on 29 November 2024. Here are 10 key things to know from the RHP.
1.Suraksha Diagnostics IPO: Key Dates
On 29 November 2024 security diagnostic The IPO will be available for subscription, and it will end on December 3, 2024. The allotment for the Suraksha Diagnostics IPO is expected to be finalized on Wednesday, December 4, 2024.
2. Security Diagnostic IPO: Size
Security Diagnostic IPO is a Bookkeeping offer of Rs 846.25 crore. The total issue is 1.92 crore shares offer for sale.
3.Security Diagnostics IPO: Subscription Details
The price band or price range for Security Diagnostic IPO is from 420 441 per share. The lot size of an application should be a minimum of 34 shares. Thus retail investors will have to make minimum investment 14,994. For Large NII, the minimum lot size investment is 67 lots (2,278 shares), or 1,004,598, and for small NII, it is 14 lots (476 shares), or 209,916.
4.Suraksha Diagnostics IPO: Listing
Suraksha Diagnostics IPO is a mainboard IPO and shares of Suraksha Diagnostics are scheduled to be listed on BSE and NSE on Friday, December 6, 2024.
5.Suraksha Diagnostics IPO: Objective of the issue
Being an offer for sale, all the proceeds will go to the selling shareholders and the company will not receive any proceeds from the issue.
6.About Suraksha Diagnostic Limited
Suraksha Diagnostic Limited was established in 2005 and provides medical consultation, radiological testing and pathology services. As of June 30, 2024, it has 215 customer touchpoints, including 49 diagnostic centers and 166 sample collection centers spread across West Bengal, Bihar, Assam and Meghalaya, in addition to its central reference laboratory and eight satellite laboratories.
7. Security Diagnostic IPO; financial position
Suraksha Diagnostics Limited saw a growth of 14.75% in revenue and 281.32% growth in net profit in FY 2024 compared to FY 2023.
8. Security Diagnostics IPO: Promoter
Dr. Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma are the promoters of the company.
9. Security Diagnostics IPO: Key Risks
95.48% of our revenues from security diagnostics operations in fiscal year 2024 were generated from West Bengal, and any loss of business in such region could adversely affect its business, results of operations and financial condition.
10. Security Diagnostic IPO: Lead Manager and Registrar
The book running lead managers of Suraksha Diagnostics IPO are ICICI Securities Ltd, Nuvama Wealth Management Ltd and SBI Capital Markets Ltd. The registrar to the issue is Kfin Technologies Limited.
